GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Veracyte Inc (FRA:12V) » Definitions » Other Gross PPE

Veracyte (FRA:12V) Other Gross PPE : €43.5 Mil (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Veracyte Other Gross PPE?

Veracyte's Other Gross PPE for the quarter that ended in Dec. 2023 was €43.5 Mil.

Veracyte's quarterly Other Gross PPE increased from Jun. 2023 (€28.6 Mil) to Sep. 2023 (€28.7 Mil) and increased from Sep. 2023 (€28.7 Mil) to Dec. 2023 (€43.5 Mil).

Veracyte's annual Other Gross PPE increased from Dec. 2021 (€37.3 Mil) to Dec. 2022 (€41.6 Mil) and increased from Dec. 2022 (€41.6 Mil) to Dec. 2023 (€43.5 Mil).


Veracyte Other Gross PPE Historical Data

The historical data trend for Veracyte's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veracyte Other Gross PPE Chart

Veracyte Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.95 20.84 37.33 41.59 43.47

Veracyte Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.59 27.44 28.58 28.66 43.47

Veracyte Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Veracyte (FRA:12V) Business Description

Traded in Other Exchanges
Address
6000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others. The company derives its revenues from the Sale of Afirma analysis products.

Veracyte (FRA:12V) Headlines

No Headlines